In August 2025, the Company completed the acquisition of Antev, a UK-based late clinical stage biotech company, developing Teverelix, a next generation GnRH antagonist, as a first in market product ...

Fund-raisers are being urged to kick-start the new year by signing up to Cancer Research UK’s Race for Life in Wigan.

Over the course of 2025, Northampton-based building materials manufacturer Forterra matched the £22,462 raised by its ...

In summer 2026, scientists at the University of Oxford and University College London plan to begin a first-of-its-kind ...

Global cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths ...

THOUSANDS of tumour samples stored in the basement of a Park Royal hospital for the past century could shed light on one of cancer’s ...

The UK National Screening Committee has opened a 12-week public consultation on whether and how prostate cancer screening ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.

An estimated 1.6 million adults in England, Wales and Scotland used drugs such as Wegovy and Mounjaro to help lose weight ...

Medicare for All remains a disastrous proposition. It would drive up wait times and create poor standards of care.

ELIGIBILITY: The NFL Style "Rep the Season" Giveaway (hereafter, "Sweepstakes") is open to legal residents of fifty (50) United States and District of Columbia who are at least eighteen (18) years of ...